Biograil™

📍 Roskilde, Denmark🗓 Founded 2019👥 29 employees💰 Last funded Apr 2024
Biograil™ is a pre-clinical stage pharmaceutical company leveraging its proprietary BIONDD™ technology to unlock the potential of transforming the tremendous market of injectable pharmaceutical products into convenient oral capsules. We strive to make the most effective and convenient pharmaceuticals to patients in innovative and prioprietary ways by combining known technologies.
4
Total investors
2
Early stage
2
Mid stage
0
Late stage
2019
Founded
Investor geography4 countries
Germany
1
Switzerland
1
United Kingdom
1
France
1
Investor activity2020–2024 · investors recorded per year
202022022120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Biograil™?
Biograil™ has 4 investors on record on gritt.io, including 2 early-stage backers, 2 mid-stage.
When did Biograil™ last raise funding?
The most recent investment in Biograil™ recorded on gritt.io was in April 2024.
When was Biograil™ founded?
Biograil™ was founded in 2019.
What industry is Biograil™ in?
Biograil™ operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Biograil™ based?
Biograil™ is headquartered in Roskilde, Denmark.